Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6455533 | J AND J CONSUMER INC | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
Jul, 2018
(5 years ago) |
Children'S Zyrtec Hives Relief is owned by J And J Consumer Inc.
Children'S Zyrtec Hives Relief contains Cetirizine Hydrochloride.
Children'S Zyrtec Hives Relief has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Children'S Zyrtec Hives Relief are:
Children'S Zyrtec Hives Relief was authorised for market use on 30 November, 2020.
Children'S Zyrtec Hives Relief is available in tablet, chewable;oral dosage forms.
Children'S Zyrtec Hives Relief can be used as treatment of seasonal and perennial allergic rhinitis symptoms.
The generics of Children'S Zyrtec Hives Relief are possible to be released after 02 July, 2018.
Drugs and Companies using CETIRIZINE HYDROCHLORIDE ingredient
Market Authorisation Date: 30 November, 2020
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, CHEWABLE;ORAL